Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.30 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.30 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20880934 | 0.76 | KMT2A (0.36) | MAPTKDM4EEGFRKMT2AMEN1 | |
| SCHEMBL20044344 | 0.76 | KMT2A (0.36) | MAPTKDM4EEGFRKMT2AMEN1 | |
| SCHEMBL24899666 | 0.75 | EGFR (0.33) | EGFR | |
| SCHEMBL29132891 | 0.73 | KDM4E (0.33) | MAPTKDM4EACHEALDH1A1HPGD | |
| SCHEMBL7045045 | 0.73 | MAPT (0.39) | MAPTKDM4EEGFRKMT2AMEN1 | |
| SCHEMBL7048653 | 0.68 | KDM4E (0.41) | MAPTKDM4EEGFRACHEKMT2A | |
| SCHEMBL30464045 | 0.68 | KDM4E (0.41) | MAPTKDM4EEGFRACHEKMT2A | |
| SCHEMBL20042468 | 0.68 | KDM4E (0.41) | MAPTKDM4EEGFRACHEKMT2A | |
| SCHEMBL14044710 | 0.66 | MAPT (0.43) | MAPTKDM4EEGFRKMT2AMEN1 | |
| SCHEMBL9964258 | 0.66 | MAPT (0.51) | MAPTKDM4EEGFRKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10991893-B2 | Organic semiconducting compounds | Raynergy Tek Incorporation (TW) | 2021-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10991893-B2 | Organic semiconducting compounds | OCIAD2, OCIAD1, OSTC | MAPT 32/4885KDM4E 704/4885EGFR 4301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.